Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus sublingual ketamine lozenges for acute pain
ACTRN12621000240842Phase 3Completed
- Sponsor
- The University of Western Australia
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine in acute pain (2 arms), sponsored by The University of Western Australia. Primary endpoints: Pain score at rest, Time to first effect and 1 more. Started Dec 2008; status: completed.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on ACTRN12621000240842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000240842.